Effects of an elemental diet to reduce adverse events in patients with esophageal cancer receiving docetaxel/cisplatin/5-fluorouracil: a phase III randomized controlled trial—EPOC 2 (JFMC49-1601-C5)

Y. Tanaka, H. Takeuchi, Y. Nakashima, H. Nagano, T. Ueno, K. Tomizuka, S. Morita, Y. Emi, Y. Hamai, J. Hihara, H. Saeki, E. Oki, C. Kunisaki, E. Otsuji, H. Baba, H. Matsubara, Y. Maehara, Y. Kitagawa, K. Yoshida

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Effects of an elemental diet to reduce adverse events in patients with esophageal cancer receiving docetaxel/cisplatin/5-fluorouracil: a phase III randomized controlled trial—EPOC 2 (JFMC49-1601-C5)'. Together they form a unique fingerprint.

Medicine & Life Sciences